Over the past several years, there has been a lot of hype about glycation and advanced glycation end-products, or AGEs, as they’ve become known to the skincare world. Yet, with all the focus on glycation, much of this condition still remains a mystery to patients and scientists alike.
Part of the mystery stems from the lack of evidence tying specific aging reactions to glycation. With so many...
Articles
Over the past several years, there has been a lot of hype about glycation and advanced...
Written content has become crucial to the success of a medical aesthetic practice....
Itsy bitsy teeny-weeny bikinis are the standard uniform among the svelte set in...
Dermatologist and dermatologic surgeon Anna D. Guanche, MD, entered medical school...
Products
SkinCeuticals Advanced Pigment Corrector clears and brightens skin by...
The Lutronic INFINI fractional radiofrequency-based system has received FDA...
Edge Systems HydraFacial Daily Essentials help patients maintain the results...
The InMode Aesthetic Platform from InMode Aesthetic Solutions allows...
Galderma Laboratories is launching a national rosacea symptom awareness campaign, called “Red is Wrong” to increase understanding of the embarrassing facial redness caused by rosacea and the treatments available to treat the skin disease.
"Red is not a good color for everything," said Stuart Raetzman, CEO of Galderma Laboratories, and vice president, Galderma North America. "We hope this campaign will encourage patients suffering with the embarrassing symptoms of rosacea to speak with their doctors about diagnosis, triggers for the facial redness and treatment options. In addition, we want to reach those who don't know why they have red faces and let them know there are treatment options available. An estimated 16 million Americans have rosacea and we hope this eye-catching campaign successfully delivers the message that they can 'right the wrong' of the facial redness associated with rosacea."
Consumers can obtain information about the disease and prescription treatment options through the print, digital and broadcast awareness campaign. The company has also launched a website, www.RedIsWrong.com, in conjunction with the campaign.
"The...
Aquavit Pharmaceuticals has announced David J. Goldberg, MD, JD, as its new chief medical officer. Dr. Goldberg is a renowned dermatologist and is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques. Prior to joining Aquavit, Dr. Goldberg has served as president of the ASLMS and is and or was on the Board of Directors of AAD, ASLMS and ASDS. Additionally, Dr. Goldberg is a clinical professor of dermatology and director of laser research at Mount Sinai School of Medicine, a clinical professor of dermatology and chief of dermatologic surgery at Rutgers New Jersey Medical School as well as the chief of dermatology at Hackensack University Medical Center and adjunct professor of law at Fordham Law School where he teaches a course entitled, "Advances in Health Care Law".
"We are thrilled to have Dr. Goldberg on board. He is an exceptional physician, researcher, and most importantly, a visionary with passion in life," said Sobin Chang, CEO of Aquavit Pharmaceuticals. "He is an entrepreneur, a perfect addition to the Aquavit team as we continue to enhance our growing product portfolio."
Ellman International, maker of the radiofrequency-based Pelleve facial skin-tightening system, has received FDA clearance to market its new PelleFirm RF Body Treatment System. The PelleFirm System is CE Marked for body skin tightening and cellulite reduction. In addition, it also has received FDA 510(K) clearance for tissue heating and the temporary reduction in the appearance of cellulite. The PelleFirm handpieces are powered by the Pelleve S5 RF Generator, which also powers the Pelleve Wrinkle Reduction handpieces for facial skin tightening.
"We have been working with physicians around the world to develop PelleFirm and are excited to bring this innovative RF body treatment system to market,” said Frank D'Amelio, president & CEO of Ellman. "With two different size handpieces, PelleFirm can address almost every area of the body. Like Pelleve, a PelleFirm RF Body Treatment system delivers visible results with no pain and no downtime."
The system will be introduced at the upcoming Annual Meeting of the American Academy of Dermatology (AAD), beginning March 21, 2014 in Denver, Colorado.
